| Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia NJ Robertson, C Meehan, KA Martinello, A Avdic-Belltheus, T Boggini, ... Cytotherapy 23 (6), 521-535, 2021 | 25 | 2021 |
| The differential effects of 2% oxygen preconditioning on the subsequent differentiation of mouse and human pluripotent stem cells K Fynes, R Tostoes, L Ruban, B Weil, C Mason, FS Veraitch Stem cells and development 23 (16), 1910-1922, 2014 | 24 | 2014 |
| Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitors OFW Gardner, N Agabalyan, B Weil, MHI Ali, MW Lowdell, NW Bulstrode, ... Cytotherapy 25 (3), 286-297, 2023 | 5 | 2023 |
| TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma. A Davies, B Sage, K Kolluri, D Alrifai, R Graham, B Weil, R Rego, O Bain, ... Journal of Clinical Oncology 37 (15_suppl), TPS9116-TPS9116, 2019 | 5 | 2019 |
| A novel filtration system for point of care washing of cellular therapy products R Tostoes, JR Dodgson, B Weil, S Gerontas, C Mason, F Veraitch Journal of Tissue Engineering and Regenerative Medicine 11 (11), 3157-3167, 2017 | 5 | 2017 |
| Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies B Weil, PJ Hanley, M Lowdell Cytotherapy 21 (3), 367-375, 2019 | 4 | 2019 |
| Bringing function to the forefront of cell therapy: how do we demonstrate potency? MW Lowdell, B Weil Frontiers in Immunology 14, 1226841, 2023 | 2 | 2023 |
| Allogeneic mesenchymal stromal cell injection to alleviate ischemic heart failure following arterial switch operation F Rapetto, D Taliotis, Q Chen, I Ttofi, D Iacobazzi, P Madeddu, SC Stoica, ... Case Reports 3 (5), 724-727, 2021 | 1 | 2021 |
| ALLOGENEIC UMBILICAL-CORD DERIVED MESENCHYMAL STROMAL CELLS MSC (UC) AS TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): SAFETY AND EARLY CLINICAL/BIOLOGICAL RESULTS FROM A … D Farge, L Biard, B Weil, S Loisel, P LANSIAUX, I Munia, V Girault, ... Cytotherapy 26 (6), S45-S46, 2024 | | 2024 |
| CAREER DEVELOPMENT GAPS AND OPPORTUNITIES: RESULTS OF THE 2023 WORKFORCE SURVEY PERFORMED BY THE ISCT EARLY-STAGE PROFESSIONALS (ESP) COMMITTEE T Mamo, PS Couto, AZ Al-Riyami, B Weil Cytotherapy 26 (6), e21-e22, 2024 | | 2024 |
| Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial A Davies, B Sage, K Kolluri, R Graham, D Alrifai, B Weil, PS Patrick, ... Lung Cancer 139, S70, 2020 | | 2020 |
| TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in metastatic lung adenocarcinoma EK Sage, A Davies, K Kolluri, D Alrifai, R Graham, B Weil, R Rego, ... HUMAN GENE THERAPY 30 (8), A8-A8, 2019 | | 2019 |
